Diagnos (TSE:ADK) has released an update.
Diagnos Inc. has successfully completed an ISO 13485 / MDSAP audit, certifying its compliance with international quality management standards for medical devices, a critical step in advancing its AI-driven healthcare solutions, including the flagship CARA product, towards commercialization in global markets. The company is poised for significant growth in the booming AI healthcare market and is working to obtain regulatory licenses in Canada and the USA for additional diagnostic modules.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.
